Rusnano Group Companies Nominated for National Prioritet 2.0 Award

04 August 2020

Six companies from the RUSNANO Group are among the nominees for the Prioritet 2.0 National Award for the Effective Adoption of Advanced Technologies. The news was announced on the official web site of the Award.

The nominees in the Electronics and Robotics and Groundbreaking Technologies categories include the Russian Flexible Electronics Centre, a member of the TechnoSpark Group, which is part of the RUSNANO Fund for Infrastructure and Educational Programs’s investment network. Russia’s first facility for the industrial production of key components for displays and sensors based on thin-film plastic electronics was opened this year in Troitsk, which is now part of Moscow.

TestGen LLC, from ULNANOTECH, the Ulianovsk nanocentre, which is another member of the RUSNANO Fund for Infrastructure and Educational Programs’s investment network, has also been nominated, in the Medicine and Healthcare and Overcoming Challenge. That last category was introduced this year, to recognize effective applications of new technologies in the fight against the coronavirus pandemic. TestGen was nominated for its development of the CoV-2-Test, which can diagnose COVID-19 infections.

“When we developed the test we did not set ourselves the goal of winning a place in a national rating or winning any other professional awards. We just wanted to make our contribution to the fight against the pandemic by providing a highly accurate diagnostic system. And our company achieved that goal: now TestGen’s system is supporting our shared struggle in Russia and several other countries. The highly efficient enzymes used in the production of the tests make it possible to identify the presence of even the smallest quantity of the virus in the test sample, and are suitable for the purposes of early-stage diagnosis,” said Andrey Toropovskiy, the company’s General Director.

Another nominee for the Overcoming Challenge category is Pharmsynthez PJSC (a RUSNANO Management Company portfolio company). Pharmsynthez is working on the development of a preventative vaccine against COVID-19 based on pseudoviral nanoparticles. Also nominated for the category Pharmaceutical and Microbiology Production is the new-generation endogenous interferon inductor NEOVIR®, a modern synthetic biostimulator medicine.

Nanolek, established with the participation of RUSNANO, is also on the list of nominees. At the height of the pandemic Nanolek presented Efferon, an extracorporeal hemoperfusion apparatus. Another high technology solution that may play a role in the fight against coronavirus is the electronic checkpoint and access management system, a combined hardware and software solution developed by MIKRON PJSC, which uses wristband sensors to measure body temperature. Between 2010 and 2016 MIKRON was part of RUSNANO’s investment portfolio.

Geosplit, a portfolio company of the Rusnano Sistema SICAR Fund (established jointly by RUSNANO JSC and Sistema JSFC) was nominated in three categories: Oil and Gas Production, High Technology Exports and Import Substitution. Geosplit’s digital models of oil deposits and underground hydrocarbon reservoirs, created by using quantum markers to monitor processes in geological formations, are in increasing demand, both in Russia and internationally.

The Prioritet awards recognize companies and new developments which promote the expansion of domestic high-technology manufacturing and help make the Russian manufacturing sector more competitive in both national and international markets. Applications can be submitted until October. The jury will vote, and the formal prizegiving ceremony will he held in the second half of October 2020, in Moscow.

Additional information

Reference

RUSNANO Joint-Stock Company was founded in March 2011 through reorganization of state corporation Russian Corporation of Nanotechnologies. JSC RUSNANO contributes to implementation of the state policy on the development of the nanotechnology industry by investing directly and through investment funds of nanotechnology in financially effective high-technology projects providing the development of new production facilities in the Russian Federation. Its primary investment focus is in electronics, optoelectronics and telecommunications, healthcare and biotechnology, metallurgy and metalwork, energy, mechanical engineering and instrument making, construction and industrial materials, chemicals and petrochemicals. 100 percent of RUSNANO’s shares are state owned. Thanks to RUSNANO’s investments, there are currently 115 factories and R&D Centers opened in 37 regions in Russia.

Management of assets of RUSNANO JSC is carried out by Limited Liability Company established in December 2013, RUSNANO Management Company. Anatoly Chubais is the Chairman of its Executive Board.

Work to establish nanotechnology infrastructure and carry out educational programs is fulfilled by RUSNANO’s Fund for Infrastructure and Educational Programs, which was also established during the reorganization of the Russian Corporation of Nanotechnologies.